Characterization of the rotenone mouse model of Parkinson's disease using radioligands for the adenosine A2A receptor ([F-18] FESCH) and the nicotinic alpha 4 beta 2 receptor ((-)-[F-18] Flubatine). Toussaint, M., Kranz, M., Schroeder, S., Lai, T. H., Deuther-Conrad, W., Dukic-Stefanovic, S., Shang, Q., Patt, M., Reichmann, H., & Funk, R. Journal of Labelled Compounds & Radiopharmaceuticals, 62:S397–S398, 2019.
bibtex   
@article{toussaint_characterization_2019,
	Author = {Toussaint, Magali and Kranz, Mathias and Schroeder, Susann and Lai, Thu Hang and Deuther-Conrad, Winnie and Dukic-Stefanovic, Sladjana and Shang, Qi and Patt, Marianne and Reichmann, Heinz and Funk, Richard},
	Journal = {Journal of Labelled Compounds \& Radiopharmaceuticals},
	Pages = {S397--S398},
	Title = {Characterization of the rotenone mouse model of {Parkinson}'s disease using radioligands for the adenosine {A}2A receptor ([{F}-18] {FESCH}) and the nicotinic alpha 4 beta 2 receptor ((-)-[{F}-18] {Flubatine})},
	Volume = {62},
	Year = {2019}}

Downloads: 0